A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India
Clinical trial NCT05891249 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05891249
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2028-12-16
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.